Sliding set-points of immune responses for therapy of autoimmunity

Journal of Experimental Medicine

Volumn 207, Issue 9, 2010, Pages 1819-1823

  Hsieh, Chyi Song ^a   Bautista, Jhoanne Lynne ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; HLA ANTIGEN; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; DIABETES MELLITUS; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHORT SURVEY;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; EPITOPES; HOMEOSTASIS; HUMANS; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 77956259249     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20101606     Document Type: Short Survey

References (31)

1. Bautista, J.L., C.W. Lio, S.K. Lathrop, K. Forbush, Y. Liang, J. Luo, A.Y. Rudensky, and C.S. Hsieh. 2009. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. 10:610-617. doi:10.1038/ni.1739
2. Bluestone, J.A., K. Herold, and G. Eisenbarth. 2010. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 464: 1293-1300. doi:10.1038/nature08933
3. Burchill, M.A., J. Yang, K.B. Vang, J.J. Moon, H.H. Chu, C.W. Lio, A.L. Vegoe, C.S. Hsieh, M.K. Jenkins, and M.A. Farrar. 2008. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity. 28:112-121. doi:10.1016/j.immuni.2007.11.022
4. Curiel, T.J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10:942-949. doi:10.1038/nm1093
5. D'Cruz, L.M., and L. Klein. 2005. Development and function of agonist-induced CD25+ Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6: 1152-1159. doi:10.1038/ni1264
6. Duarte, J.H., S. Zelenay, M.L. Bergman, A.C. Martins, and J. Demengeot. 2009. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur. J. Immunol. 39:948-955. doi:10.1002/eji.200839196
7. Fontenot, J.D., J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6:1142-1151. doi:10.1038/ni1263
8. Grinberg-Blayer, Y., A. Baeyens, S. You, R. Elhage, G. Fourcade, S. Gregoire, N. Cagnard, W. Carpentier, Q. Tang, J. Bluestone, et al. 2010. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J. Exp. Med. 207:1871-1878.
9. Hsieh, C.S., Y. Zheng, Y. Liang, J.D. Fontenot, and A.Y. Rudensky. 2006. An intersection between the self-reactive regulatory and non-regulatory T cell receptor repertoires. Nat. Immunol. 7:401-410. doi:10.1038/ni1318
10. Knoechel, B., J. Lohr, E. Kahn, J.A. Bluestone, and A.K. Abbas. 2005. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202:1375-1386. doi:10.1084/jem.20050855
11. Koebel, C.M., W. Vermi, J.B. Swann, N. Zerafa, S.J. Rodig, L.J. Old, M.J. Smyth, and R.D. Schreiber. 2007. Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 450:903-907. doi:10.1038/nature06309
12. Lathrop, S.K., N.A. Santacruz, D. Pham, J. Luo, and C.S. Hsieh. 2008. Antigen-specific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 205:3105-3117. doi:10.1084/jem.20081359
13. + cells is limited to small clonal sizes. J. Exp. Med. 206:2121-2130. doi:10.1084/jem.20091033
14. Li, M.O., S. Sanjabi, and R.A. Flavell. 2006. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 25:455-471. doi:10.1016/j.immuni.2006.07.011
15. Lio, C.W., and C.S. Hsieh. 2008. A two-step process for thymic regulatory T cell development. Immunity. 28:100-111. doi:10.1016/j.immuni.2007.11.021
16. Malek, T.R. 2008. The biology of interleukin-2. Annu. Rev. Immunol. 26:453-479. doi:10.1146/annurev.immunol.26.021607.090357
17. Malek, T.R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity. 17:167-178. doi:10.1016/S1074-7613(02)00367-9
18. Marie, J.C., D. Liggitt, and A.Y. Rudensky. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity. 25:441-454. doi:10.1016/j.immuni.2006.07.012
19. Nishio, J., M. Feuerer, J. Wong, D. Mathis, and C. Benoist. 2010. Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints. J. Exp. Med. 207:1879-1889.
20. O'Gorman, W.E., H. Dooms, S.H. Thorne, W.F. Kuswanto, E.F. Simonds, P.O. Krutzik, G.P. Nolan, and A.K. Abbas. 2009. The initial phase of an immune response functions to activate regulatory T cells. J. Immunol. 183:332-339. doi:10.4049/jimmunol.0900691
21. Pacholczyk, R., H. Ignatowicz, P. Kraj, and L. Ignatowicz. 2006. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity. 25:249-259. doi:10.1016/j.immuni.2006.05.016
22. Pandiyan, P., L. Zheng, S. Ishihara, J. Reed, and M.J. Lenardo. 2007. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8:1353-1362. doi:10.1038/ni1536
23. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036. doi:10.1126/science.1078231
24. Putnam, A.L., T.M. Brusko, M.R. Lee, W. Liu, G.L. Szot, T. Ghosh, M.A. Atkinson, and J.A. Bluestone. 2009. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes. 58:652-662. doi:10.2337/db08-1168
25. Roncarolo, M.G., and M. Battaglia. 2007. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 7:585-598. doi:10.1038/nri2138
26. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
27. - precursor to Foxp3+ regulatory T cells in peripheral lymphoid organs of nonmanipulated mice. J. Exp. Med. 207:1393-1407. doi:10.1084/jem.20100045
28. Smolen, J.S., R. Landewé, F.C. Breedveld, M. Dougados, P. Emery, C. Gaujoux-Viala, S. Gorter, R. Knevel, J. Nam, M. Schoels, et al. 2010. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69: 964-975. doi:10.1136/ard.2009.126532
29. Tang, Q., K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, J. Ye, E.L. Masteller, H. McDevitt, M. Bonyhadi, and J.A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199:1455-1465. doi:10.1084/jem.20040139
30. Tang, Q., J.Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C.A. Piccirillo, B.L. Salomon, and J.A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 28:687-697. doi:10.1016/j.immuni.2008.03.016
31. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199:1467-1477. doi:10.1084/jem.20040180